Cargando…
IDO1 involvement in mTOR pathway: a molecular mechanism of resistance to mTOR targeting in medulloblastoma
Medulloblastoma (MB) is the most common malignant brain tumor in children. Despite therapeutic advancements, high-risk groups still present significant mortality. A deeper knowledge of the signaling pathways contributing to MB formation and aggressiveness would help develop new successful therapies....
Autores principales: | Folgiero, Valentina, Miele, Evelina, Carai, Andrea, Ferretti, Elisabetta, Alfano, Vincenzo, Po, Agnese, Bertaina, Valentina, Goffredo, Bianca Maria, Benedetti, Maria Chiara, Camassei, Francesca Diomedi, Cacchione, Antonella, Locatelli, Franco, Mastronuzzi, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288157/ https://www.ncbi.nlm.nih.gov/pubmed/27174915 http://dx.doi.org/10.18632/oncotarget.9284 |
Ejemplares similares
-
MBCL-18. ANALYSIS OF DNA METHYLATION PROFILES OF PEDIATRIC MEDULLOBLASTOMAS: EXPERIENCE AT THE BAMBINO GESÙ CHILDREN’S HOSPITAL
por: Miele, Evelina, et al.
Publicado: (2020) -
Targeting mTOR as a Therapeutic Approach in Medulloblastoma
por: Aldaregia, Juncal, et al.
Publicado: (2018) -
Anomalous vascularization in a Wnt medulloblastoma: a case report
por: Di Giannatale, Angela, et al.
Publicado: (2016) -
mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012) -
Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)